Brazil regulator says documents still missing for fast-track COVID-19 vaccine approval

Brazil's health regulator Anvisa said on Thursday that it still requires further documentation before it can approve emergency use requests for COVID-19 vaccines developed by AstraZeneca PLC and China Sinovac Biotech.

Anvisa has scheduled a meeting on Sunday to decide on the fast-track approvals that would allow vaccination to get under way in Brazil next week.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)